|Articles|December 3, 2002

Microtek Medical Acquires Gyrus Drape Product Line

COLUMBUS, Miss. -- Microtek Medical Holdings, Inc. announces that its wholly-owned subsidiary Microtek Medical, Inc. has signed a definitive agreement to acquire the drape product line of Gyrus ENT, LLC. The acquisition will strengthen Microtek's market position in the disposable drape market and was completed on November 29, 2002. The Company estimates this transaction will add revenues of approximately $3 million annually and expects the transaction to be accretive to earnings.

For Gyrus ENT, LLC, the sale of its drape product line is part of its strategy of divesting selected non-core businesses in order to focus on its global ENT opportunities.

Financial terms of the agreement were not disclosed.

Dan R. Lee, Microtek's president and CEO stated, "I am very pleased to announce Microtek's acquisition of this drape product line. This transaction is a result of our ongoing growth initiatives, which include in part strategic and accretive acquisitions. We strongly believe that this product line acquisition is a unique and natural fit within our Company and one that will provide top-line revenue contribution as well as significant bottom-line potential. We believe that we can integrate this product line into our operations without incurring any significant fixed manufacturing or fixed operating expense which should result in an attractive operating margin on this incremental business. We are also confident that the transition of this product line to Microtek will be of great benefit to the Gyrus customers. All of this translates to enhanced revenue growth, improved profitability and increased value for our shareholders."

Source: PRNewswire


Related to this article

Infection preventionists in full PPE with children in DRC.  (Image credit: author with AI)
Nearly 4 months into the DRC's Bundibugyo virus disease outbreak, some indicators suggest transmission may be slowing. But shifting hotspots, treatment-center capacity problems, community deaths, and incomplete surveillance data show why national case totals alone cannot determine whether containment has been achieved.
Health care workers from the US speaking with other health care workers in DRC.  (Image credit: author with AI)
Is the Ebola outbreak in the DRC getting better? The answer depends on which numbers you examine. Several important indicators are moving in the right direction, including slower case growth and a declining Rₜ. But major gaps remain in contact tracing, testing, community deaths, safe burial coverage, and treatment capacity in some of the hardest-hit areas. ICT takes a deeper look at the latest outbreak data and why the numbers suggest cautious optimism, not victory.
Dyan Troxell, MSN, RN, director of clinical education at HandCraft Linen Services; J.J. Odom, MBA, CHESP, CMIP, T-CHEST, university director of buildings and grounds for UConn Health and chair-elect of the AHE Board; and Jenna Rivers, MPH, CPH, CIC, manager of infection prevention and control at Moffitt Cancer Center in Tampa, Florida.
At AHE Exchange 2026, ICT spoke with experts representing commercial laundry services, EVS, and infection prevention about the systems behind a successful reusable linen program. They discuss linen quality, reject rates, unnecessary waste, frontline education, data, PAR levels, infection prevention oversight, and why strong relationships between health care facilities and their laundry providers matter.
A group of students raising their hands in class during a lecture  (Adobe Stock 292282454 by Mediteraneo
How do you celebrate an infection that never happened? That's one of the unusual challenges infection preventionists share with teachers. Both can spend their careers changing outcomes they may never see. Both educate people who don't always want to listen. Both are second-guessed. Both face burnout. And both must somehow keep remembering why they started.